12/09/2025
Heads-up 💡: generic Semaglutide is on the horizon — big implications for diabetes and weight-management care.
While exact U.S. timing remains uncertain, many international markets are already preparing for lower-cost commercially available semaglutide injectable medications.
For people who rely on branded drugs today, this means: stay alert. Soon, access could open up — but supply, quality, and regulatory timing will be crucial.
https://firstwordpharma.com/story/6730936
Novo Nordisk lost a Delhi High Court case seeking to block Dr. Reddy's Laboratories from manufacturing and exporting generic versions of its diabetes and wei...